Source: Journal Pharmacogenomics Pharmacoproteomics. Unidade: FCF
Subjects: POLIMORFISMO, METALOPROTEINASES, LINFOTOXINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Jéssica Bassani et al. Polymorphisms in genes encoding metalloproteinase 9 and lymphotoxin- alpha can influence warfarin treatment. Journal Pharmacogenomics Pharmacoproteomics, v. 6, n. 1, p. 1-6, 2015Tradução . . Disponível em: https://doi.org/10.4172/2153-0645.1000143. Acesso em: 09 nov. 2024.APA
Borges, J. B., Hirata, T. D. C., Cerda, A., Fajardo, C. M., Cesar, R. C. C., França, J. I. D., et al. (2015). Polymorphisms in genes encoding metalloproteinase 9 and lymphotoxin- alpha can influence warfarin treatment. Journal Pharmacogenomics Pharmacoproteomics, 6( 1), 1-6. doi:10.4172/2153-0645.1000143NLM
Borges JB, Hirata TDC, Cerda A, Fajardo CM, Cesar RCC, França JID, Santos JC, Wang H-TL, Liporace IL, Castro LR, Sampaio MF, Souza AG de MR, Hirata RDC, Hirata MH. Polymorphisms in genes encoding metalloproteinase 9 and lymphotoxin- alpha can influence warfarin treatment [Internet]. Journal Pharmacogenomics Pharmacoproteomics. 2015 ; 6( 1): 1-6.[citado 2024 nov. 09 ] Available from: https://doi.org/10.4172/2153-0645.1000143Vancouver
Borges JB, Hirata TDC, Cerda A, Fajardo CM, Cesar RCC, França JID, Santos JC, Wang H-TL, Liporace IL, Castro LR, Sampaio MF, Souza AG de MR, Hirata RDC, Hirata MH. Polymorphisms in genes encoding metalloproteinase 9 and lymphotoxin- alpha can influence warfarin treatment [Internet]. Journal Pharmacogenomics Pharmacoproteomics. 2015 ; 6( 1): 1-6.[citado 2024 nov. 09 ] Available from: https://doi.org/10.4172/2153-0645.1000143